Finland's Paula Salmikangas reappointed as vice-chair of EMA's advanced therapies panel
This article was originally published in Clinica
Executive Summary
Paula Salmikangas of Finland's drug agency, Fimea, has been reappointed as vice-chair of the European Medicines Agency's Committee for Advanced Therapies for a second three-year term.